Related references
Note: Only part of the references are listed.Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
Victor J. Weigman et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Analysis of KLLN as a high-penetrance breast cancer predisposition gene
Ella R. Thompson et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
Min-Han Tan et al.
CLINICAL CANCER RESEARCH (2012)
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
Cynthia X. Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
A Clinical Scoring System for Selection of Patients for PTEN Mutation Testing Is Proposed on the Basis of a Prospective Study of 3042 Probands
Min-Han Tan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Germline and Somatic DNA Methylation and Epigenetic Regulation of KILLIN in Renal Cell Carcinoma
Kristi L. Bennett et al.
GENES CHROMOSOMES & CANCER (2011)
Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53
Xin He et al.
HUMAN MOLECULAR GENETICS (2011)
Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence
Ben Zhang et al.
LANCET ONCOLOGY (2011)
CHK1 Inhibitors in Combination Chemotherapy Thinking Beyond the Cell Cycle
Paul Dent et al.
MOLECULAR INTERVENTIONS (2011)
Determinants of translation efficiency and accuracy
Hila Gingold et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Germline copy number variation and cancer risk
Roland P. Kuiper et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Germline Epigenetic Silencing of the Tumor Suppressor Gene PTPRJ in Early-Onset Familial Colorectal Cancer
Ramprasath Venkatachalam et al.
GASTROENTEROLOGY (2010)
Germline Epigenetic Regulation of KILLIN in Cowden and Cowden-like Syndrome
Kristi L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Origins and functional impact of copy number variation in the human genome
Donald F. Conrad et al.
NATURE (2010)
Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes
Ying Ni et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Tenets of PTEN tumor suppression
Leonardo Salmena et al.
CELL (2008)
The emerging landscape of breast cancer susceptibility
Michael R. Stratton et al.
NATURE GENETICS (2008)
Integrated detection and population-genetic analysis of SNPs and copy number variation
Steven A. McCarroll et al.
NATURE GENETICS (2008)
Killin is a p53-regulated nuclear inhibitor of DNA synthesis
Yong-jig Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Rameen Beroukhim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
Triple-negative breast cancer: therapeutic options
Susan Cleator et al.
LANCET ONCOLOGY (2007)
Cancer phenomics: RET and PTEN as illustrative models
Kevin M. Zbuk et al.
NATURE REVIEWS CANCER (2007)
Models of genetic susceptibility to breast cancer
A. C. Antoniou et al.
ONCOGENE (2006)
Modifiers of risk of hereditary breast cancer
S. A. Narod
ONCOGENE (2006)
p53 Down-regulates phosphatase and tensin homologue deleted on chromosome 10 protein stability partially through caspase-mediated degradation in cells with proteasome dysfunction
Yufang Tang et al.
CANCER RESEARCH (2006)
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
W Han et al.
BMC CANCER (2006)
Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies
SJ Shukla et al.
PHARMACOGENOMICS (2005)
Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast
S Tsutsui et al.
ONCOLOGY (2005)
Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals
JV Chamary et al.
GENOME BIOLOGY (2005)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Chk1 and Chk2 kinases in checkpoint control and cancer
J Bartek et al.
CANCER CELL (2003)
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
JB Duan et al.
HUMAN MOLECULAR GENETICS (2003)
Familial breast cancer: scope for more susceptibility genes?
K Hemminki et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
RI Yarden et al.
NATURE GENETICS (2002)
The ETS-domain transcription factor family
AD Sharrocks
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
'Other' breast cancer susceptibility genes: searching for more holy grail
KL Nathanson et al.
HUMAN MOLECULAR GENETICS (2001)
Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR
S Goldstone et al.
ONCOGENE (2001)
Codon usage tabulated from international DNA sequence databases: status for the year 2000
Y Nakamura et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
